Literature DB >> 22552786

Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies.

Vicent Esteve1, Bernardo Celda, M Carmen Martínez-Bisbal.   

Abstract

Quantitative multinuclear high-resolution magic angle spinning was performed in order to determine the tissue pH values of and the absolute metabolite concentrations in 33 samples of human brain tumour tissue. Metabolite concentrations were quantified by 1D (1)H and (31)P HRMAS using the electronic reference to in vivo concentrations (ERETIC) synthetic signal. (1)H-(1)H homonuclear and (1)H-(31)P heteronuclear correlation experiments enabled the direct assessment of the (1)H-(31)P spin systems for signals that suffered from overlapping in the 1D (1)H spectra, and linked the information present in the 1D (1)H and (31)P spectra. Afterwards, the main histological features were determined, and high heterogeneity in the tumour content, necrotic content and nonaffected tissue content was observed. The metabolite profiles obtained by HRMAS showed characteristics typical of tumour tissues: rather low levels of energetic molecules and increased concentrations of protective metabolites. Nevertheless, these characteristics were more strongly correlated with the total amount of living tissue than with the tumour cell contents of the samples alone, which could indicate that the sampling conditions make a significant contribution aside from the effect of tumour development in vivo. The use of methylene diphosphonic acid as a chemical shift and concentration reference for the (31)P HRMAS spectra of tissues presented important drawbacks due to its interaction with the tissue. Moreover, the pH data obtained from (31)P HRMAS enabled us to establish a correlation between the pH and the distance between the N(CH(3))(3) signals of phosphocholine and choline in (1)H spectra of the tissue in these tumour samples.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552786     DOI: 10.1007/s00216-012-6001-z

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  6 in total

1.  Development of a three-dimensional cell culture system based on microfluidics for nuclear magnetic resonance and optical monitoring.

Authors:  Vicent Esteve; Javier Berganzo; Rosa Monge; M Carmen Martínez-Bisbal; Rosa Villa; Bernardo Celda; Luis Fernandez
Journal:  Biomicrofluidics       Date:  2014-11-18       Impact factor: 2.800

Review 2.  Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.

Authors:  Christopher Dietz; Felix Ehret; Francesco Palmas; Lindsey A Vandergrift; Yanni Jiang; Vanessa Schmitt; Vera Dufner; Piet Habbel; Johannes Nowak; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-09-15       Impact factor: 4.044

Review 3.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

Review 4.  Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS).

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Metabolites       Date:  2016-03-22

5.  Magnetic Resonance Spectroscopy-based Metabolomic Biomarkers for Typing, Staging, and Survival Estimation of Early-Stage Human Lung Cancer.

Authors:  Yannick Berker; Lindsey A Vandergrift; Isabel Wagner; Li Su; Johannes Kurth; Andreas Schuler; Sarah S Dinges; Piet Habbel; Johannes Nowak; Eugene Mark; Martin J Aryee; David C Christiani; Leo L Cheng
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

6.  Pitfalls to be considered on the metabolomic analysis of biological samples by HR-MAS.

Authors:  Vicent Esteve; Beatriz Martínez-Granados; M Carmen Martínez-Bisbal
Journal:  Front Chem       Date:  2014-05-30       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.